Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 32.9B | 47.1B | 25.6B | 27.6B |
Cost of revenue | 30.8B | 41.9B | 22.7B | 24.5B |
Gross profit | 2.1B | 5.2B | 2.9B | 3.1B |
Operating expense | ||||
Research & development | 391.4M | 305.2M | 342.3M | 292.6M |
Selling general and admin | 2.3B | 3.0B | 2.0B | 1.9B |
Other operating expenses | 59.1M | -37.7M | 53.0M | 166.8M |
Operating income | -3.3B | -234.0M | -1.6B | -1.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -1.9B | -3.4B | 2.4B | -1.8B |
Tax provision | 0 | — | 615.3K | — |
Net income | -1.9B | -3.4B | 2.4B | -1.8B |
Basic EPS | — | -313 | 226 | -142 |
Diluted EPS | — | -313 | 226 | -142 |
Basic average shares | — | 11.0M | 10.7M | — |
Diluted average shares | — | 11.0M | 10.7M | — |
EBITDA | 1.8B | 225.0M | -1.3B | -1.4B |
Net income from continuing op. | -1.9B | — | 2.4B | -1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |